Locations:

Tag: INTERMACS

December 10, 2021/Heart, Vascular and Thoracic/Heart Failure & Transplant

PDE-5 Inhibitors May Benefit Patients After Centrifugal-Flow LVAD Implant

Outcome benefits from large registry lay groundwork for a randomized controlled trial

August 18, 2020/Heart, Vascular and Thoracic/Research

Post-Implant PDE5 Inhibitor Therapy Lowers Thrombotic Events in LVAD Patients

INTERMACS analysis sets the stage for a confirmatory randomized trial

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy